This inventor holds 1 USPTO granted patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hweirung Amy Wang: Innovator in Complement-Associated Treatments
Introduction
Hweirung Amy Wang is a notable inventor based in Oak Park, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of complement-associated conditions. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Hweirung Amy Wang holds a patent titled "Subcutaneous (SC) Administration of Anti-C5 Antibodies for Treatment of Complement-Associated Conditions." This patent represents a breakthrough in therapeutic approaches, providing new options for patients suffering from related health conditions. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Wang is currently employed at Alexion Pharmaceuticals, Inc., a company renowned for its focus on developing innovative therapies for rare diseases. His role at Alexion has allowed him to work on cutting-edge research and contribute to the advancement of treatment options in the pharmaceutical industry.
Collaborations
Throughout his career, Hweirung Amy Wang has collaborated with esteemed colleagues, including Dino C. Miano and Tatyana Mezhebovsky. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.
Conclusion
Hweirung Amy Wang is a distinguished inventor whose work in the field of complement-associated treatments has the potential to improve patient outcomes significantly. His contributions to medical science through his patent and collaborations highlight his dedication to innovation and excellence in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
